siRNA, Anti-AGGF1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT41537WQ-2OMe)

The product SIRGT41537WQ-2OMe is a type of small interfering RNA (siRNA) that targets AGGF1 gene and regulates the expression of gene. The siRNA interferes with the expression of AGGF1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_018046.4
Alternative Names GPATC7; GPATCH7; HSU84971; HUS84971; VG5Q
Related Diseases Frontal Convexity Meningioma
Purification HPLC
Target Gene
Gene ID 55109
Uniprot ID Q8N302
Sub Cat Target Species Modification Scale  
SIRGT42537WQ-2F AGGF1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT43537WQ-2MOE AGGF1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT44537WQ-LNA AGGF1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT41537WQ-RB AGGF1 Human Ribo-modified Inquiry
SIRGT42537WQ-BB AGGF1 Human Backbone-modified Inquiry

Related Products